metaPreg - Diltiazem (versus unexposed) during pregnancy

Diltiazem (versus unexposed)

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	0.75 [0.10, 5.67]	-	1 study	34	29	not evaluable	ROB	-
Limb defects	3.61 [0.18, 71.49]	-	1 study	3	29	not evaluable	ROB	-
Major congenital malformations	0.86 [0.05, 14.73]	-	1 study	14	29	not evaluable	ROB	-
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	3.75 [1.45, 9.65]	-	1 study	53	29	not evaluable	ROB	6.95 [2.27; .]
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine death (< 22 weeks)	2.43 [0.97, 6.07]	-	1 study	65	36	not evaluable	ROB	-
Elective/induced termination of pregnancy	4.43 [1.73, 11.35]	-	1 study	36	41	not evaluable	ROB	8.34 [2.86; .]
Late intrauterine deaths (> 22 weeks)	1.72 [0.09, 31.08]	-	1 study	6	35	not evaluable	ROB	-
Hide endpoints reported in only one study ...